LeslieAAndritsosMD

PubMed

• Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia.
  Heerema, N. A., Muthusamy, N., Zhao, Q., Ruppert, A. S., Breidenbach, H., Andritsos, L. A., Grever, M. R., Maddocks, K. J., Woyach, J., Awan, F., Long, M., Gordon, A.,...> ;Haematologica. 2020 May 18
• Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.
  Andritsos, L. A., Huang, Y., Abraham, I., Huff, K., Scrape, S. R., Fan, T., Alkhatib, N., Hofmeister, C. C., Drea, E., McBride, A.> ;Leukemia research. 2019 Aug 31
• A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia.
  Andritsos, L. A., Byrd, J. C., Cheverton, P., Wu, J., Sivina, M., Kipps, T. J., Burger, J. A.> ;Leukemia & lymphoma. 2019 Jul 30
• Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood an...
  Kansagra, A. J., Frey, N. V., Bar, M., Laetsch, T. W., Carpenter, P. A., Savani, B. N., Heslop, H. E., Bollard, C. M., Komanduri, K. V., Gastineau, D. A., Chabannon, C...> ;Bone marrow transplantation. 2019 May 17
• Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.
  Yucebay, F., Matthews, C., Puto, M., Li, J., William, B., Jaglowski, S. M., Penza, S. L., Vasu, S., Benson, D. M., Andritsos, L. A., Devine, S. M., Efebera, Y. A., Rod...> ;Leukemia & lymphoma. 2019 Feb 16
• Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.
  McWilliams, E. M., Lucas, C. R., Chen, T., Harrington, B. K., Wasmuth, R., Campbell, A., Rogers, K. A., Cheney, C. M., Mo, X., Andritsos, L. A., Awan, F. T., Woyach, J...> ;Blood advances. 2019 Feb 10
• BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas.
  Singer, S., Sharma, N., Dean, R., Zhao, Q., Abounader, D., Elder, P., Hofmeister, C. C., Benson, D. M., Rosko, A., Penza, S., Andritsos, L., Vasu, S., Jaglowski, S., W...> ;Bone marrow transplantation. 2019 Feb 6
• BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
  Singer, S., Dean, R., Zhao, Q., Sharma, N., Abounader, D., Elder, P., Hofmeister, C. C., Benson, D. M., Rosko, A., Penza, S., Andritsos, L., Vasu, S., Jaglowski, S., W...> ;Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Feb 5
• Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib.
  Shenoi, D. P., Andritsos, L. A., Blachly, J. S., Rogers, K. A., Moran, M. E., Anghelina, M., Jones, J. A., Grever, M. R.> ;Blood advances. 2019 Jan 12
• Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Tran...
  Kansagra, A. J., Frey, N. V., Bar, M., Laetsch, T. W., Carpenter, P. A., Savani, B. N., Heslop, H. E., Bollard, C. M., Komanduri, K. V., Gastineau, D. A., Chabannon, C...> ;Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Dec 24
• Cutaneous adverse events associated with purine analogs in the treatment of hairy cell leukemia.
  Wang, R. F., Kuehn, G. J., Andritsos, L. A., Grever, M. R., Kaffenberger, B. H.> ;International journal of dermatology. 2018 Nov 28
• Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?
  Vaughn, J. L., Zhao, Q., Epperla, N., Puto, M., Roddy, J., Elder, P., Blum, W., Klisovic, R., Jaglowski, S., Penza, S., William, B., Andritsos, L., Brammer, J. E., Hof...> ;Bone marrow transplantation. 2018 Nov 11
• Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues.
  Wang, R. F., Li, D., Kuehn, G. J., Andritsos, L. A., Grever, M. R., Kaffenberger, B. H.> ;Journal of the American Academy of Dermatology. 2018 Sep 12
• The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation.
  Reiff, S. D., Mantel, R., Smith, L. L., Greene, J. T., Muhowski, E. M., Fabian, C. A., Goettl, V. M., Tran, M., Harrington, B. K., Rogers, K. A., Awan, F. T., Maddocks...> ;Cancer discovery. 2018 Aug 11
• Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre.
  Rogers, K. A., Huang, Y., Dotson, E., Lundberg, J., Andritsos, L. A., Awan, F. T., Woyach, J. A., Byrd, J. C.> ;British journal of haematology. 2018 Jul 22
• Detection of toxigenic <i>Clostridium difficile</i> colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation.
  Vaughn, J. L., Balada-Llasat, J., Lamprecht, M., Huang, Y., Anghelina, M., Boghdadly, Z. E., Bishop-Hill, K., Childs, R., Pancholi, P., Andritsos, L. A.> ;Journal of medical microbiology. 2018 Jun 5
• Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients.
  Richardson, D. R., Huang, Y., McGinty, H. L., Elder, P., Newlin, J., Kirkendall, C., Andritsos, L. A., Benson, D. M., Blum, W., Efebera, Y. A., Penza, S., Hofmeister, ...> ;Bone marrow transplantation. 2018 Feb 16
• A retrospective review of fall risk factors in the bone marrow transplant inpatient service.
  Vela, C. M., Grate, L. M., McBride, A., Devine, S., Andritsos, L. A.> ;Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2017 Dec 30
• A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyo...
  Rogers, K. A., Huang, Y., Ruppert, A. S., Salem, G., Stephens, D. M., Heerema, N. A., Andritsos, L. A., Awan, F. T., Byrd, J. C., Flynn, J. M., Maddocks, K. J., Jones,...> ;British journal of haematology. 2017 Dec 2
• 1 citation
  Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.
  Andritsos, L. A., Grieselhuber, N. R., Anghelina, M., Rogers, K. A., Roychowdhury, S., Reeser, J. W., Timmers, C. D., Freud, A. G., Blachly, J. S., Lucas, D. M., Lozan...> ;Leukemia &amp; lymphoma. 2017 Sep 19
• Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy.
  Vaughn, J. L., Kline, D., Denlinger, N. M., Andritsos, L. A., Exline, M. C., Walker, A. R.> ;Leukemia &amp; lymphoma. 2017 Sep 14
• 9 citations
  Ibrutinib treatment improves T cell number and function in CLL patients.
  Long, M., Beckwith, K. A., Do, P., Mundy, B. L., Gordon, A., Lehman, A. M., Maddocks, K. J., Cheney, C., Jones, J. A., Flynn, J. M., Andritsos, L. A., Awan, F. T., Fra...> ;The Journal of clinical investigation. 2017 Jul 18
• 24 citations
  PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
  Haverkos, B. M., Abbott, D., Hamadani, M., Armand, P., Flowers, M. E., Merryman, R. W., Kamdar, M., Kanate, A. S., Saad, A., Mehta, A., Ganguly, S., Fenske, T. S., Har...> ;Blood. 2017 May 5
• 24 citations
  BTK^C481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.
  Woyach, J. A., Ruppert, A. S., Guinn, D., Lehman, A., Blachly, J. S., Lozanski, A., Heerema, N. A., Zhao, W., Coleman, J., Jones, D., Abruzzo, L. V., Gordon, A., Mante...> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Apr 19
• 3 citations
  The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.
  Guinn, D., Lehman, A., Fabian, C., Yu, L., Maddocks, K., Andritsos, L. A., Jones, J. A., Flynn, J. M., Jaglowski, S. M., Woyach, J. A., Byrd, J. C., Johnson, A. J.> ;Cancer medicine. 2017 Mar 17
• Join now to see all

Lectures

• Infection at the Time of Initial Therapy for Hairy Cell Leukemia Is Associated with Inferior Time to Next Treatment 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018